Form 4: AVANOS Medical Officer Reports Routine Tax Withholding Share Disposition

AVANOS Medical's Principal Accounting Officer, John Joseph Hurley, reported the disposition of 345 common shares to cover tax obligations from vested restricted stock units.

Summary

• John Joseph Hurley, Principal Accounting Officer of AVANOS Medical, Inc. (AVNS), reported a transaction involving the company's common stock.
• On September 5, 2025, Hurley disposed of 345 shares of common stock at a price of $12.66 per share.
• This disposition was made to the issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs).
• The TRSUs were originally awarded to Hurley on September 5, 2024, with each TRSU being the economic equivalent of one share of Common Stock.
• Following this transaction, Hurley beneficially owns 11,364 shares of AVANOS Medical common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation and tax obligations. It is neutral in its implications for the company's financial health or strategic direction.

Positives

• The transaction is a routine event related to executive compensation, indicating the vesting of previously awarded restricted stock units.
• The officer continues to hold a significant number of shares (11,364), aligning their interests with shareholders.

Negatives

• No specific negative aspects are identified as this is a standard tax-related transaction.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on a past and scheduled insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically related to executive compensation and tax obligations. Such transactions are common across all industries when restricted stock units or similar equity awards vest for corporate officers. It does not provide insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact. This is a routine, non-discretionary transaction for tax purposes, not a discretionary sale indicating a change in management's confidence. The officer retains a substantial holding.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary disposition of shares by a Principal Accounting Officer to satisfy tax withholding obligations upon the vesting of restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamentals or management's outlook. The officer retains a significant equity stake. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.

Keywords

AVANOS Medical, AVNS, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, John Joseph Hurley, Principal Accounting Officer, Equity Compensation